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Tian, J.H., Xu, W., Fang, Y., Mogil, J.S., Grisel, J.E., Grandy, D.K., MuÈ ller cells contain receptors for most of the molecules
and Han, J.S. (1997). Br. J. Pharmacol. 120, 676±680. that have been shown to rescue photoreceptors; they
become stimulated, as indicated by the expression of
glial fibrillary acidic protein (GFAP), in response to a
variety of toxic stimuli, including retinal degeneration
(Ekstrom et al., 1998); transgenic experiments suggest
that loss of MuÈ ller cells leads to photoreceptor deathNeurotrophic Rescue of
(Dubois-Dauphin et al., 2000); and MuÈ ller cells, but notPhotoreceptors: Are MuÈ ller Cells
photoreceptors, are consistently activated by intraocu-
the Mediators of Survival? lar administration of BDNF, CNTF, and basic fibroblast
growth factor (FGF2), as measured by increased expres-
sion of the immediate-early protein c-fos and the phos-
phorylated form of the extracellular signal±regulated ki-Neuronal death in the retina has been studied not only
nase (pERK) (Wahlin et al., 2000).because of its own biological importance and its rele-
Although suggestive of a role for MuÈ ller cells in pro-vance to clinical disease, but also because retinal apo-
tecting photoreceptor cells from apoptosis, all of theptosis serves as a model system for death elsewhere
data just cited is itself indirect and fails to provide muchin the central nervous system (Nickells and Zack, 1996).
insight as to the mechanism by which MuÈ ller cells mightNeurodegenerative retinal diseases in which apoptosis
rescue photoreceptors. Harada et al. (2000), in this issuehas been implicated include photoreceptor degenera-
of Neuron, present new information that provides moretions such as retinitis pigmentosa and age-related de-
direct support for the MuÈ ller cell hypothesis and sug-generation, retinal ganglion cell diseases such as glau-
gests involvement of the low-affinity p75NTR neurotrophincoma and other optic neuropathies, and more panretinal
receptor in photoreceptor death in the adult retina. (Pre-diseases like diabetic retinopathy. In an effort to develop
vious work had already implicated p75NTR in cell deathnovel treatment approaches for these diseases, various
during retinal development [Casademunt et al., 1999].)anti-apoptotic strategies have been explored. Trans-
Using the phototoxicity model of retinal degeneration,genically engineered overexpression of bcl-2 in retinal
in which high-intensity and/or prolonged light exposureganglion cells leads to an inhibition of developmental
leads to photoreceptor cell loss, they show that degen-apoptosis and relative resistance of ganglion cells to
eration is associated with an increase in MuÈ ller celltoxic insults such as optic nerve axotomy. Although
expression of p75NTR and TrkC, and induction of TrkCmore controversial, some results suggest that bcl-2
expression by photoreceptor cells. Administration of ex-overexpression can also protect photoreceptors from
ogenous NT-3, which is photoreceptor cell protective,damage (Chen et al., 1996). Perhaps more promising
increased MuÈ ller cell production of FGF2, while NGFfrom a clinical point of view, neurotrophic factors, which
decreased its production. Functionally, they demon-inhibit neuronal apoptosis in a wide variety of systems,
strate that presumptive antibody-mediated blockade ofinhibit ganglion and photoreceptor cell death both in
p75NTR signaling prolongs photoreceptor survival. Mostvitro and in vivo (Steinberg, 1994; LaVail et al., 1998).
significantly, they show that in p75NTR null mice there isThe mechanism by which neurotrophic factors protect
a decrease in photoreceptor injury following light expo-photoreceptor cells from degeneration is unclear. Con-
sure. Putting this all together, the authors suggest atrol of neuronal survival by neurotrophins is generally
model in which there is a fine balance between pro- andmediated by two types of receptors: the Trk family of
antiapoptotic forces: MuÈ ller cells, acting in response tohigh-affinity tyrosine kinase receptors (TrkA, B, and C),
exogenous NT-3 or NGF via TrkC or p75NTR receptors,which usually transmit a prosurvival signal, and the neu-
respectively, increase or decrease their production ofrotrophin receptor p75NTR, which transmits an anti-sur-
the photoreceptor survival factor FGF2, which in turnvival signal (Casaccia-Bonnefil, 1999). A paradox in the
results in either the protection of photoreceptor cells orphotoreceptor field is that although brain-derived neuro-
increased apoptosis. In addition, since light-damagedtrophic factor (BDNF) and ciliary neurotrophic factor
photoreceptors express TrkC, NT-3 may also act directly(CNTF) have been consistently reported as neuroprotec-
upon injured photoreceptors. Interestingly, a similartive for rod photoreceptor cells, thus suggesting that
glial±neuronal interaction model has been proposed forthe corresponding receptors, TrkB and CNTFRa, are
the mechanism by which BDNF promotes retinal bipolarexpressed by these cells, most studies have thus far
cell survival in vitro (Wexler et al., 1998).failed to find evidence that mammalian rods express
An important innovation in the work by Harada et al.either TrkB or CNTFRa (Ugolini et al., 1995; Kirsch et al.,
is the use of laser capture microdissection (LCM) for the1997). As a result, it has been proposed that neurotophic
study of gene expression in subtypes of retinal cells.rescue of photoreceptors may be indirect, mediated by
Using LCM in conjunction with RT±PCR, they succeedinteraction of the neurotrophic factor with a nonphotore-
in measuring gene expression differences between pho-ceptor cell type that in turn releases a secondary factor,
toreceptors and inner nuclear layer cells. Although notor perhaps by a cell contact±mediated mechanism. Sev-
fully exploited in this study, LCM has the potential toeral lines of evidence suggest that the MuÈ ller cell may be
allow study of complex patterns of gene expressionan important player in this indirect rescue mechanism.
between neighboring and interacting cell populations.MuÈ ller cells are the predominant glial element in the
In a recent study, LCM was combined with cDNA mi-retina, and they carry out many of the functions provided
croarray analysis to compare the in vivo gene expressionby astrocytes, oligodendrocytes, and ependymal cells
elsewhere in the CNS (Newman and Richenbach, 1996). profiles of large and small dorsal root ganglia neurons
Neuron
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Kirsch, M., Lee, M.Y., Meyer, V., Wiese, A., and Hofmann, H.D. (1997).(Luo et al., 1999). This approach will be particularly use-
J. Neurochem. 68, 979±990.ful to correlate functional and gene expression changes
LaVail, M.M., Yasumura, D., Matthes, M.T., Lau-Villacorta, C., Unoki,within small regions of the retina, and, since much of
K., Sung, C.H., and Steinberg, R.H. (1998). Invest. Ophthalmol. Vis.retinal disease is focal, to compare neighboring regions
Sci. 39, 592±602.
of normal versus diseased tissue.
Luo, L., Salunga, R.C., Guo, H., Bittner, A., Joy, K.C., Galindo, J.E.,
As impressive and suggestive as the results of Harada Xiao, H., Rogers, K.E., Wan, J.S., Jackson, M.R., and Erlander, M.G.
et al. are, it is worth considering some potential caveats (1999). Nat. Med. 5, 117±122.
before extending their results too broadly. The specific- Newman, E., and Richenbach, A. (1996). Trends Neurosci. 19,
ity of the immunological and pharmacological blocking 307±312.
reagents used in the study is good, but not absolute. Nickells, R.W., and Zack, D.J. (1996). Ophthalmic Genet. 17,
The light toxicity model is only one of many available 145±165.
retinal degeneration models, including naturally oc- Steinberg, R.H. (1994). Curr. Opin. Neurobiol. 4, 515±524.
curring mouse mutants (such as rd); mouse, rat, and Ugolini, G., Cremisi, F., and Maffei, L. (1995). Brain Res. 704,
121±124.pig transgenic models; and an increasing number of
knockout models. In fact, photoxicity is considered by Wahlin, K.J., Campochiaro, P.A., Zack, D.J., and Adler, R. (2000).
Invest. Ophthalmol. Vis. Sci. 41, 927±936.some in the field to be one of the less physiological
Wexler, E.M., Berkovich, O., and Nawy, S. (1998). Vis. Neurosci. 15,models. Although all models examined seem to share
211±218.apoptosis as the final common pathway of photorecep-
tor death, it is now abundantly clear that apoptosis is
not a single, simple pathway. There are significant differ-
ences between the various photoreceptor degeneration
models, and even species differences within the same
model. As one example, photoreceptors in mice that are
null for the c-fos gene are relatively resistant to light
damage but die just like wild-type cells in the rd model
(Hafezi et al., 1998). As another example, the effective-
ness of neurotrophins as rescue agents varies signifi-
cantly between mammalian species. Thus, it will be im-
portant to directly test whether the results of Harada et
al. do indeed extend to other models and other species,
and it will be particularly interesting to determine
whether the p75NTR null mice are resistant to other forms
of retinal degeneration. Regardless of the results, how-
ever, it is clear that this piece of work will help focus
interest on the importance of glial±neuronal cell interac-
tions within the retina, and in the role these interactions
may play in degenerative diseases of the retina.
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